(Q44766209)

English

A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.

scientific article published on 10 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ivan Fan Ngai Hung

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

9

object named as

Man-Fung Yuen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

John Chi-Hang Yuen

6

object named as

John Chi-Hang Yuen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Danny Ka-Ho Wong

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Teresa Tong

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

0 references

publication date

10 July 2012

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

56

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

812-819

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Calculating correlation coefficients with repeated observations: Part 2--Correlation between subjects

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Quantitative Hepatitis B Surface Antigen Levels in Patients With Chronic Hepatitis B After 2 Years of Entecavir Treatment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

21 January 2018

Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

7 January 2021

based on heuristic

inferred from DOI database lookup

A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral determinants of hepatitis B surface antigen seroclearance in hepatitis B e antigen-negative chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

7 January 2021

based on heuristic

inferred from DOI database lookup

Index for rating diagnostic tests

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.25718

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.25718

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

release_5whrxlo7bjch7mges4axtzzdyi

1 reference

https://api.fatcat.wiki/v0/release/5whrxlo7bjch7mges4axtzzdyi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22422518%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44766209&oldid=1835579286"